Astrocytes are a primary target of neuronal-derived BDNF: a novel mechanism for dysfunction in Rett Syndrome
Astrocytes are a primary target of neuronal-derived BDNF: a novel mechanism for dysfunction in Rett Syndrome
批准号:
9256598
负责人:
Leanne Holt
金额:
$4.4万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-01 至 2020-02-29
关键词:
AddressAdultAffectAnimalsAstrocytesBlood - brain barrier anatomyBrainBrain-Derived Neurotrophic FactorBreathingCell physiologyCellsComplexCoupledDataDevelopmentDiseaseExhibitsFemaleFoundationsFunctional disorderGap JunctionsGastrointestinal DiseasesGenetic TechniquesGenetic TranscriptionGoalsGolgi ApparatusGrantGrowth FactorHandHippocampus (Brain)HomeostasisHumanImaging TechniquesIn VitroKnock-outLabelLeadLightMaintenanceMediatingMediator of activation proteinMessenger RNAMethyl-CpG-Binding Protein 2Molecular GeneticsMorphologyMutationNeuraxisNeurodevelopmental DisorderNeuronsNeurotrophic Tyrosine Kinase Receptor Type 2PatientsPharmacologyPopulationProcessPublicationsPublishingRNA SequencesReceptor SignalingRett SyndromeRodentRoleSeizuresSignal TransductionSpinal CordStructureSynapsesTestingTimeUp-RegulationWorkcell growthcell typecritical periodexperiencein vivomRNA Expressionmature animalnervous system disorderneurodevelopmentneuronal cell bodyneuronal growthneurotransmitter reuptakenovelpostnatalreceptorreduce symptomsresponsestereotypy
中文摘要
项目摘要/摘要
成熟的星形胶质细胞可以说是中枢神经系统中形态最复杂的细胞。这
复杂性与这种细胞类型的几个最有特点的功能有关,包括
神经递质再摄取、K+稳态和血脑屏障的维持。虽然我们知道
发育时间窗当星形胶质细胞形态成熟和细化时,我们所知甚少
关于这一过程的其他信息。脑源性神经营养因子(BDNF)是一种重要的生长因子,主要由
神经元,参与神经元的发育和成熟,包括神经元的生长和突触
精致。我们为这笔赠款产生的初步数据表明,星形胶质细胞表达高水平
脑源性神经营养因子受体TrkB与神经元相比。特别是,TrkB的截断版本TrkB.T1是
优势受体表达。TrkB.T1在星形胶质细胞中表达最高
星形胶质细胞的形态细化和成熟,这也是一个发育的时间窗口
符合神经元BDNF的最高表达水平。脑源性神经营养因子表达缺失是
神经发育障碍Rett综合征,最近的出版物表明星形胶质细胞有一个
显著降低了形态的复杂性,在这种疾病中是功能失调的。这些发现导致了
BDNF/TrkB.T1信号是星形胶质细胞形态的重要调节因子的假设
成熟和神经元BDNF表达减少通过调节星形胶质细胞功能障碍
Rett综合征的星形胶质细胞形态。我们建议检测BDNF对星形胶质细胞形态的影响
利用体外和体内分子、遗传和成像技术的组合。此外,我们还将
检测脑源性神经营养因子/TrkB.T1信号降低是否与Rett综合征的星形胶质细胞形态异常有关
这可能有助于阐明星形胶质细胞功能障碍是如何导致这种毁灭性的
疾病。
英文摘要
Project Summary/Abstract
Mature astrocytes are arguably the most morphologically complex cells in the central nervous system. This
complexity is associated with several of the most well characterized functions of this cell type, including
neurotransmitter reuptake, K+ homeostasis, and blood-brain barrier maintenance. While we know the
developmental time window when astrocyte morphological maturation and refinement occurs, we know little
else about this process. Brain derived neurotrophic factor (BDNF) is a critical growth factor secreted largely by
neurons and involved in the development and maturation of neurons, including neuronal growth and synapse
refinement. Preliminary data we have generated for this grant demonstrates that astrocytes express high levels
of the BDNF receptor TrkB when compared to neurons. In particular, the truncated version of TrkB, TrkB.T1 is
the predominate receptor expressed. TrkB.T1 expression is highest in astrocytes during the critical period of
astrocyte morphological refinement and maturation, a developmental time window which also happens to
coincide with highest neuronal BDNF expression levels. Loss of BDNF expression is a hallmark of
neurodevelopment disorder Rett Syndrome, and recent publications indicate that astrocytes have a
significantly reduced morphological complexity and are dysfunctional in this disease. These findings have led
us to the hypothesis that BDNF/TrkB.T1 signaling is an important mediator of astrocyte morphological
maturation and that reduced neuronal BDNF expression contributes to astrocyte dysfunction by modulating
astrocyte morphology in Rett Syndrome. We propose to examine BDNF’s influence on astrocyte morphology
utilizing a combination of in vitro and in vivo molecular, genetic, and imaging techniques. Additionally, we will
examine if reduced BDNF/TrkB.T1 signaling contribute to aberrant astrocyte morphology in Rett syndrome
which may shed light on how astrocyte dysfunction contributes to the pathophysiology of this devastating
disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金